Literature DB >> 15590191

Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.

Susan L Tucker1, Lei Dong, Rex Cheung, Jennifer Johnson, Radhe Mohan, Eugene H Huang, H Helen Liu, Howard D Thames, Deborah Kuban.   

Abstract

PURPOSE: To compare the fits of normal-tissue complication probability (NTCP) models based on rectal dose-wall histograms (DWHs) vs. dose-volume histograms (DVHs) when the two are used to analyze a common set of late rectal toxicity data. METHODS AND MATERIALS: Data were analyzed from 128 prostate cancer patients treated with 3-dimensional conformal radiotherapy (3D-CRT) at The University of Texas M.D. Anderson Cancer Center (UTMDACC). The DVH for total rectal volume, including contents, was obtained for each patient from the treatment-planning system. A DWH was also computed, using the outer rectal contour plus an autogenerated inner contour that corresponds to an assumed 3-mm rectal wall thickness. The endpoint for analysis was Grade 2 or higher late rectal bleeding within 2 years of treatment; all patients had at least 2 years of follow-up. Four different NTCP models were fitted to the response data by using either the DVH or the DWH to describe the dose distribution to rectum or rectal wall, respectively. The 4 models considered were the Lyman model, the mean dose model, the parallel-architecture model, and a model based on the volume of a organ receiving more than a specified dose (the "cutoff-dose" model).
RESULTS: For each of the models, the fit to the late rectal bleeding data was slightly improved when the analysis was based on the rectal DWH instead of on the DVH. In addition, the results of the cutoff dose and parallel architecture models were consistent with one another for the DWH data but not for the DVH data. For the DWH data, both models predict a 50% or higher incidence of Grade 2 or worse late rectal bleeding within 2 years if 80% or more of the rectal wall is exposed to doses greater than 32 Gy. A 50% or higher incidence of rectal bleeding is also predicted if the mean dose to rectal wall exceeds 53.2 Gy.
CONCLUSIONS: A consistent, although modest, improvement occurs in the fits of NTCP models to the UTMDACC 2-year late rectal bleeding data when the fit is based on the rectal dose-wall histogram instead of on the dose-volume histogram for entire rectum, including contents.

Entities:  

Mesh:

Year:  2004        PMID: 15590191     DOI: 10.1016/j.ijrobp.2004.07.712

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

1.  Acute anal toxicity after whole pelvic radiotherapy in patients with asymptomatic haemorrhoids: identification of dosimetric and patient factors.

Authors:  H Jang; J G Baek; S-J Yoo
Journal:  Br J Radiol       Date:  2015-04-15       Impact factor: 3.039

2.  Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.

Authors:  Søren M Bentzen; Louis S Constine; Joseph O Deasy; Avi Eisbruch; Andrew Jackson; Lawrence B Marks; Randall K Ten Haken; Ellen D Yorke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

3.  On the impact of functional imaging accuracy on selective boosting IMRT.

Authors:  Y Kim; W A Tomé
Journal:  Phys Med       Date:  2008-01-18       Impact factor: 2.685

4.  Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans.

Authors:  Yusung Kim; Wolfgang A Tome
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

5.  Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?

Authors:  Mirko Nitsche; Werner Brannath; Matthias Brückner; Dirk Wagner; Alexander Kaltenborn; Nils Temme; Robert M Hermann
Journal:  Br J Radiol       Date:  2016-12-12       Impact factor: 3.039

6.  Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Authors:  Susan L Tucker; Lei Dong; Walter R Bosch; Jeff Michalski; Kathryn Winter; Radhe Mohan; James A Purdy; Deborah Kuban; Andrew K Lee; M Rex Cheung; Howard D Thames; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-02       Impact factor: 7.038

7.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer.

Authors:  M Rex Cheung; Susan L Tucker; Lei Dong; Renaud de Crevoisier; Andrew K Lee; Steven Frank; Rajat J Kudchadker; Howard Thames; Radhe Mohan; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-22       Impact factor: 7.038

8.  Dosimetric impact in the dose-volume histograms of rectal and vesical wall contouring in prostate cancer IMRT treatments.

Authors:  Laura Gómez; Carlos Andrés; Antonio Ruiz
Journal:  Rep Pract Oncol Radiother       Date:  2017-04-21

Review 9.  The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Authors:  Sarah L Kerns; Suman Kundu; Jung Hun Oh; Sandeep K Singhal; Michelle Janelsins; Lois B Travis; Joseph O Deasy; A Cecile J E Janssens; Harry Ostrer; Matthew Parliament; Nawaid Usmani; Barry S Rosenstein
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

10.  Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.

Authors:  Simona Marzi; Biancamaria Saracino; Maria G Petrongari; Stefano Arcangeli; Sara Gomellini; Giorgio Arcangeli; Marcello Benassi; Valeria Landoni
Journal:  J Exp Clin Cancer Res       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.